DK2684056T3 - Method of monitoring anticoagulant therapy - Google Patents

Method of monitoring anticoagulant therapy Download PDF

Info

Publication number
DK2684056T3
DK2684056T3 DK12748059.8T DK12748059T DK2684056T3 DK 2684056 T3 DK2684056 T3 DK 2684056T3 DK 12748059 T DK12748059 T DK 12748059T DK 2684056 T3 DK2684056 T3 DK 2684056T3
Authority
DK
Denmark
Prior art keywords
plasma
factor
coagulation
test
fiix
Prior art date
Application number
DK12748059.8T
Other languages
Danish (da)
English (en)
Inventor
Pall Torfi Onundarson
Brynja R Gudmundsdottir
Original Assignee
Flix Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flix Diagnostics filed Critical Flix Diagnostics
Application granted granted Critical
Publication of DK2684056T3 publication Critical patent/DK2684056T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK12748059.8T 2011-03-08 2012-03-08 Method of monitoring anticoagulant therapy DK2684056T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS050010A IS2809B (is) 2011-03-08 2011-03-08 Blóðstorkumæling
PCT/IS2012/050005 WO2012120546A2 (en) 2011-03-08 2012-03-08 Method for monitoring anticoagulant therapy

Publications (1)

Publication Number Publication Date
DK2684056T3 true DK2684056T3 (en) 2017-07-10

Family

ID=46682867

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12748059.8T DK2684056T3 (en) 2011-03-08 2012-03-08 Method of monitoring anticoagulant therapy

Country Status (9)

Country Link
US (2) US9234902B2 (cg-RX-API-DMAC7.html)
EP (1) EP2684056B1 (cg-RX-API-DMAC7.html)
CN (1) CN103534595B (cg-RX-API-DMAC7.html)
DK (1) DK2684056T3 (cg-RX-API-DMAC7.html)
ES (1) ES2636318T3 (cg-RX-API-DMAC7.html)
IN (1) IN2013MN01890A (cg-RX-API-DMAC7.html)
IS (1) IS2809B (cg-RX-API-DMAC7.html)
RU (1) RU2607658C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012120546A2 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015154090A1 (en) * 2014-04-04 2015-10-08 Bloodworks Routine laboratory and point-of-care (poc) testing for hemostasis
EP3140650B1 (en) * 2014-05-05 2022-07-20 Haemonetics Corporation Methodologies and reagents for detecting fibrinolysis and hyperfibrinolysis
SE540132C2 (sv) * 2014-05-22 2018-04-10 Zafena Ab Analysmetod för bestämning av antikoagulanter i blod eller blodplasma
CN110822822B (zh) 2014-06-09 2021-08-24 泰尔茂比司特公司 冻干法
JP6871673B2 (ja) * 2015-03-31 2021-05-12 学校法人東日本学園 血液検体を判定するための方法、装置及びコンピュータプログラム、並びに血液検体分析装置
WO2016170944A1 (ja) * 2015-04-24 2016-10-27 公立大学法人奈良県立医科大学 血液検体の凝固能の評価方法、並びにその方法に用いるための試薬、試薬キット及び装置
EP3401686B1 (en) * 2016-01-07 2022-10-05 Fujimori Kogyo Co., Ltd. Method for analyzing blood characteristics
RU2655302C1 (ru) * 2017-05-15 2018-05-24 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования эффективности антикоагулянтной терапии у больных с фибрилляцией предсердий, перенесших инсульт
RU2660706C1 (ru) * 2017-09-26 2018-07-09 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ПМ" Минздрава России) Скрининг-тест определения контактного пути коагуляции (СТОКПК)
CN111295094A (zh) 2017-10-09 2020-06-16 泰尔茂比司特生物技术有限公司 冻干容器及使用冻干容器的方法
CN109459420B (zh) * 2018-12-29 2021-06-04 华南师范大学 一种水体中二/三价铁离子的检测方法
WO2020242552A1 (en) 2019-03-14 2020-12-03 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
CN110361531B (zh) * 2019-08-02 2023-04-11 天津医科大学总医院 一种检测微粒促凝活性的实验方法
US20220373566A1 (en) * 2019-10-17 2022-11-24 Nova Biomedical Corporation Coagulation assay apparatus and methods thereof
CN114544983A (zh) * 2022-02-28 2022-05-27 南京可诺医疗技术有限公司 一种凝血与血小板功能分析仪用正常值质控品的制备方法
CN114778858A (zh) * 2022-06-23 2022-07-22 深圳市帝迈生物技术有限公司 一种狼疮抗凝物检测试剂盒
WO2025132651A1 (en) * 2023-12-20 2025-06-26 Pentapharm Ag Method for analyzing a blood sample with respect to a hemostatic regulator
WO2025186634A1 (en) 2024-03-04 2025-09-12 Fiix Diagnostics Method and kit for monitoring anticoagulant therapy
US12405281B1 (en) 2024-03-04 2025-09-02 Fiix Diagnostics Method and kit for monitoring anticoagulant therapy

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL238873A (cg-RX-API-DMAC7.html) * 1958-05-16
US3395210A (en) * 1964-02-07 1968-07-30 Warner Lambert Pharmaceutical Lyophilized diagnostic reagent for the determination of blood coagulation factors
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
DE3413311A1 (de) 1984-04-09 1985-10-17 Behringwerke Ag, 3550 Marburg Reagenz zur bestimmung der thromboplastinzeit
AU2870992A (en) 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
US5447440A (en) * 1993-10-28 1995-09-05 I-Stat Corporation Apparatus for assaying viscosity changes in fluid samples and method of conducting same
US6194394B1 (en) 1998-07-01 2001-02-27 Sigma-Aldrich Co. Coagulation controls for prothrombin time (PT) and activated partial thromboplastin time (APTT) assays
CN1255637A (zh) * 1998-09-03 2000-06-07 希森美康株式会社 抗凝血剂及血液检查方法
CN1806176A (zh) 2003-05-16 2006-07-19 国家生物标准及控制研究所 混合物
ZA200601974B (en) * 2003-09-22 2007-05-30 Haematex Res Pty Ltd Method for detecting procoagulant phospholipid
SE0303249D0 (sv) * 2003-12-02 2003-12-02 Inst Polymerutveckling Ab Hematocrit and analyte concentration determination
CN1952169B (zh) * 2005-10-18 2010-05-12 上海太阳生物技术有限公司 临床检验凝血酶原时间(pt)测定体外诊断试剂盒
CN101221189B (zh) * 2007-01-12 2012-08-15 上海太阳生物技术有限公司 一种用于测定活化部分凝血活酶时间aptt的体外诊断试剂盒
CN101526538B (zh) * 2008-03-09 2014-04-09 上海长岛生物技术有限公司 液体白陶土aptt试剂
EP2177624A1 (en) 2008-10-02 2010-04-21 Siemens Healthcare Diagnostics Products GmbH Blood coagulation assays

Also Published As

Publication number Publication date
EP2684056A2 (en) 2014-01-15
WO2012120546A3 (en) 2012-11-29
ES2636318T3 (es) 2017-10-05
RU2607658C2 (ru) 2017-01-10
IS2809B (is) 2012-10-15
CN103534595A (zh) 2014-01-22
US20120231485A1 (en) 2012-09-13
US20160108457A1 (en) 2016-04-21
EP2684056B1 (en) 2017-05-03
RU2013144950A (ru) 2015-04-20
CN103534595B (zh) 2016-03-09
IN2013MN01890A (cg-RX-API-DMAC7.html) 2015-09-25
US9234902B2 (en) 2016-01-12
WO2012120546A2 (en) 2012-09-13

Similar Documents

Publication Publication Date Title
DK2684056T3 (en) Method of monitoring anticoagulant therapy
Lebreton et al. Thrombin generation and cirrhosis: state of the art and perspectives
Favaloro et al. The new oral anticoagulants and the future of haemostasis laboratory testing
AU757459B2 (en) Inhibition of coagulation in blood and blood products
Brinkman Global assays and the management of oral anticoagulation
CA2792126C (en) Diagnostic kit, container containing the diagnostic kit and method, for the determination of coagulation characteristics of a test liquid
Barrowcliffe Monitoring haemophilia severity and treatment: new or old laboratory tests?
WO2008093216A1 (en) Diagnostic composition and its use in the determination of coagulation characteristics of a test liquid
BR112014031509B1 (pt) Para a determinação simultânea in vitro em tempo real do curso da atividade da enzima proteolítica e da resistência do coágulo de fibrina, reômetro rotativo e uso de um reômetro rotativo
Gudmundsdottir et al. Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time
US20100227346A1 (en) Activation Mixture
ES2321125T3 (es) Procedimiento para la estandarizacion de ensayos de coagulacion.
US20110177541A1 (en) Method for adjusting the coagulation time in calibrator or control plasmas
CN109082458B (zh) 一种血栓弹力图法定量检测口服凝血因子Xa抑制剂试剂盒及其制备方法
EP2405274A1 (en) Monitoring anticoagulant therapy and identifying reversible direct factor Xa inhibitors
US12405281B1 (en) Method and kit for monitoring anticoagulant therapy
US20250355004A1 (en) Method and kit for monitoring anticoagulant therapy
Hellstern Composition of plasma
ES2377437T3 (es) Procedimiento para determinar la actividad de coagulación total de una muestra de sangre o plasma
Mendelsohn et al. Effects of platelets and platelet‐derived material on the activated partial thromboplastin time (Cephotest®) coagulation test
Hedner et al. Recent advances in clot biology and assessment of clotting
Ponjee et al. One-step chromogenic equivalent of activated partial thromboplastin time evaluated for clinical application
Hellstern Composition of plasma
J Neamah et al. A Comparative Study Between the Effect of Hydrochlorothiazide and Furosemide on the Anticoagulant Activity of Warfarin